European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

OBJECTIVE: Novel disease-specific and mechanism-based treatments sharing good evidence of efficacy for migraine have been recently marketed. However, reimbursement by insurers depends on treatment failure with classic anti-migraine drugs. In this systematic review and meta-analysis, we aimed to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Deligianni, Christina I., Sacco, Simona, Ekizoglu, Esme, Uluduz, Derya, Gil-Gouveia, Raquel, MaassenVanDenBrink, Antoinette, Ornello, Raffaele, Sanchez-del-Rio, Margarita, Reuter, Uwe, Versijpt, Jan, de Vries, Tessa, Hussain, Muizz, Zeraatkar, Dena, Lampl, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507915/
https://www.ncbi.nlm.nih.gov/pubmed/37723437
http://dx.doi.org/10.1186/s10194-023-01657-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507915/
https://www.ncbi.nlm.nih.gov/pubmed/37723437
http://dx.doi.org/10.1186/s10194-023-01657-3

Ejemplares similares